A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

被引:0
|
作者
Lewis, D. [1 ]
Winner, P. [2 ]
Saper, J. [3 ]
Ness, S. [4 ]
Polverejan, E. [5 ]
Kurland, C. [6 ]
Ford, L. [4 ]
Eerdekens, M. [7 ]
机构
[1] Childrens Hosp Kings Daughters, Eastern Virginia Med Sch, Div Pediat Neurol, Norfolk, VA USA
[2] Palm Beach Headache Ctr, W Palm Beach, FL USA
[3] Michigan Head Pain & Neurol Inst, Ann Arbor, MI USA
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Translat Med, Titusville, NJ USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Clin Biostat, Titusville, NJ USA
[6] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Mature Prod TA Operat, Titusville, NJ USA
[7] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Analgesia, Antwerp, Belgium
来源
HEADACHE | 2008年 / 48卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S8 / S9
页数:2
相关论文
共 50 条
  • [41] Evaluating the Efficacy and Safety of Erenumab (AMG 334) In Chronic Migraine Prevention in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
    Tepper, Stewart
    Widnell, Katherine
    Dolezil, David
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan Lewis
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Dan
    NEUROLOGY, 2017, 88
  • [42] Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Sonbolestan, Seyed Ali
    Heshmat, Kiyan
    Javanmard, Shaghayegh Haghjooy
    Saadatnia, Mohammad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (01) : 72 - 77
  • [43] Montelukast for migraine prophylaxis: A randomized, double-blind, placebo-controlled study
    Brandes, JL
    Visser, WH
    Farmer, MV
    Schuhl, AL
    Malbecq, W
    Vrijens, F
    Lines, CR
    Reines, SA
    HEADACHE, 2004, 44 (06): : 581 - 586
  • [44] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [45] Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine
    Whitmarsh, TE
    ColestonShields, DM
    Steiner, TJ
    CEPHALALGIA, 1997, 17 (05) : 600 - 604
  • [46] Oxcarbazepine in migraine headache - A double-blind, randomized, placebo-controlled study
    Silberstein, S.
    Saper, J.
    Berenson, F.
    Somogyi, M.
    McCague, K.
    D'Souza, J.
    NEUROLOGY, 2008, 70 (07) : 548 - 555
  • [47] A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome
    Jankovic, J.
    Jimenez-Shahed, J.
    Brown, L. W.
    MOVEMENT DISORDERS, 2009, 24 : S497 - S497
  • [48] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and afety of Erenumab in Migraine Prevention: Primary Results of the ARISE Trial
    Dodick, D. W.
    Ashina, M.
    Kudrow, D.
    Lanteri-Minet, M.
    Osipova, V
    Palmer, K.
    Picard, H.
    Mikol, D. D.
    Lenz, R. A.
    HEADACHE, 2017, 57 : 191 - 192
  • [49] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [50] A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB IN MIGRAINE PREVENTION: PRIMARY RESULTS OF THE ARISE TRIAL
    Dodick, David
    Ashina, Messoud
    Kudrow, David
    Lanteri-Minet, Michel
    Osipova, Vera
    Palmer, Kerry
    Picard, Hernan
    Mikol, Daniel D.
    Lenz, Robert A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):